Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Influenza
Research
Federal mRNA vax grant cuts includes unrelated project
Tiba Biotech's siRNA flu therapeutic was included in the BARDA mRNA vaccine cuts for unclear reasons.
Darren Incorvaia
Aug 7, 2025 2:20pm
Moderna's flu/COVID vaccine hit by deprioritization, FDA delay
May 1, 2025 7:24am
CDC data on influenza, bird flu go missing as outbreaks escalate
Feb 19, 2025 9:45am
AI drug discoverer's antiviral reduces COVID in mouse lungs
Jan 21, 2025 12:42am
FDA clears at-home COVID/flu combo test with eye on fall season
Oct 8, 2024 11:05am
Nasal spray protects mice from deadly flu
Oct 2, 2024 8:54am
